BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
Copyright ©The Author(s) 2025.
World J Gastrointest Pathophysiol. Dec 22, 2025; 16(4): 111306
Published online Dec 22, 2025. doi: 10.4291/wjgp.v16.i4.111306
Table 1 Complete metabolic panel showing elevated liver enzymes the following day after high-dose methylprednisolone
Variable
Patient values
Normal range
AST22415-41 U/L
Alkaline phosphatase11132-91 U/L
Total bilirubin0.80.3-1.0 mg/dL
Calcium9.18.6-10.4 mg/dL
Total protein6.45.8-8.2 g/dL
Albumin4.03.5-5.1 g/dL
Glucose, blood21170-139 mg/dL
BUN166-20 mg/dL
Creatinine0.600.44-1.03 mg/dL
BUN/creatinine ratio24.210.0-20.0 mgUN/mgCR
Sodium, blood141136-145 mmol/L
Potassium, blood4.43.5-5.1 mmol/L
Chloride, blood10798-107 mmol/L
Osmolality, calculated298275-295 mOsm/kg
CO22522-32 mmol/L
Anion gap94-15 mmol/L
ALT2337-52 U/L
CKD-EPI eGFR100> 59 mL/minute/1.73 m2
Table 2 Naranjo adverse drug reaction probability scale for the patient
Question
Yes
No
Do not know
Score
Are there previous conclusive reports on this reaction?+ 100+ 1
Did the adverse event appear after the suspected drug was administered?+ 2- 10+ 2
Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?+ 100+ 1
Did the adverse reaction reappear when the drug was readministered?+ 2- 100
Are there alternative causes (other than the drug) that could on their own have caused the reaction?- 1+ 20+ 2
Did the reaction reappear when a placebo was given?- 1+ 100
Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?+ 1000
Was the reaction more severe when the dose was increased or less severe when the dose was decreased?+ 1000
Did the patient have a similar reaction to the same or similar drugs in any previous exposure?+ 1000
Was the adverse event confirmed by any objective evidence?+ 100+ 1
Total score7